Protocol · Cardiovascular Health
Peripheral Arterial Disease (PAD) Supportive Care Protocol
Omega-3 Fatty Acids and L-Arginine are the core of this stack, with 7 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Peripheral Arterial Disease (PAD) Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
9 supplements · 1 graded
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file | Shop |
|---|---|---|---|---|---|
| Primary stackThe core of this protocol | |||||
| Omega-3 Fatty Acids | Amount listed: 2–4 g EPA+DHA daily | Reduces triglycerides; anti-inflammatory; may improve endothelial function and blood flow | Not graded yet | ||
| L-Arginine | Amount listed: 6–8 g daily in divided doses | Nitric oxide precursor; promotes vasodilation; may improve walking distance in claudication
| Grade C for Blood Flow1 study · 39 people | ||
| Supporting stackListed as additions to the core | |||||
| L-Carnitine/Propionyl-L-Carnitine | Amount listed: 2–3 g propionyl-L-carnitine daily | Improves muscle metabolism; studied for claudication symptoms; may extend walking distance | Not graded yet | ||
| Ginkgo Biloba | Amount listed: 120–240 mg standardized extract daily | Improves peripheral circulation; antioxidant; studied for claudication with modest benefit
| Not graded yet | ||
| Vitamin E | Amount listed: 400–800 IU daily (mixed tocopherols) | Antioxidant; may improve blood flow; mixed evidence for PAD symptoms | Not graded yet | ||
| Coenzyme Q10 | Amount listed: 100–200 mg daily | Supports mitochondrial function; antioxidant; may improve exercise capacity | Not graded yet | ||
| Niacin (Vitamin B3) | Amount listed: 500–2,000 mg daily (extended-release; monitor with physician) | Improves lipid profile; vasodilator; studied as adjunct therapy for PAD | Not graded yet | ||
| Vitamin D | Amount listed: 2,000–4,000 IU daily | Deficiency associated with worse PAD outcomes; supports vascular function | Not graded yet | ||
| Garlic | Amount listed: 600–1,200 mg aged garlic extract daily | May improve blood flow; lipid-lowering effects; traditional cardiovascular remedy | Not graded yet | ||
Shop the evidence-backed picks
Support alongside medical care. These supplements are not a treatment for Peripheral Arterial Disease (PAD). If you are being treated for it, talk to your clinician before adding one: supplements can interact with medicines.
The collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
Each opens third-party tested products, matched to the dose above where we can.
- Grade C
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
How this protocol works
In plain language
Peripheral Arterial Disease (PAD), also called Peripheral Arterial Occlusive Disease (PAOD), occurs when arteries that supply blood to the legs become narrowed or blocked by atherosclerosis (fatty deposits). This reduces blood flow to the legs and can cause pain during walking (claudication), poor wound healing, and in severe cases, gangrene requiring amputation.
SYMPTOMS of PAD:
- Leg pain, cramping, or fatigue when walking (claudication)
- Pain that improves with rest
- Cool skin on legs or feet
- Hair loss on legs
- Weak pulses in feet
- Slow-healing wounds on feet or legs
- Numbness or weakness in legs
- Erectile dysfunction (in men)
CRITICAL: PAD is a serious condition indicating widespread atherosclerosis. People with PAD have high risk of heart attack and stroke.
MEDICAL TREATMENT:
- Antiplatelet therapy: Aspirin, clopidogrel
- Statin medications: Reduce cardiovascular events
- Blood pressure control: Target <130/80
- Diabetes management: If diabetic
- Cilostazol: FDA-approved medication for claudication
- Revascularization: Angioplasty, stenting, bypass surgery for severe disease
LIFESTYLE MODIFICATIONS (Essential):
- Supervised exercise therapy: Most effective non-surgical treatment
- Smoking cessation: CRITICAL - smoking is major risk factor
- Healthy diet: Mediterranean-style
- Weight management
L-Arginine* is a nitric oxide precursor that may improve blood flow and walking distance.
Propionyl-L-Carnitine* has Cochrane review evidence for modestly improving walking distance.
Omega-3 Fatty Acids* reduce inflammation and support vascular health.
Expected timeline: Walking programs typically show improvement in 3-6 months. Supplements may provide modest additional benefit over 2-3 months.